Skip to main content
Premium Trial:

Request an Annual Quote

Paul Nadler, Fred Hassan, Richard Jay Kogan

Premium

Paul Nadler has been named vice president of medical research for Branford, Conn.-based Cellular Genomics. Nadler is the managing general partner of Nadler Pharma Associates, a consulting firm. Previously, he was chief medical officer for Kern McNeill International. Nadler holds an MD from Washington University School of Medicine.

 

Fred Hassan was named chief executive officer of Schering-Plough and will become chairman of the board, the company said. He will replace Richard Jay Kogan, who announced his intention to retire in November. Hassan previously was chairman and CEO of Pharmacia. Hassan holds a BS in chemical engineering from Imperial College of Science and Technology of the University of London and an MBA from Harvard University.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.